CD274 and non-small cell lung carcinoma: A recent study of patients with NSCLC treated with different drugs active on the PD-1/PD-L1 axis across multiple lines showed a non-statistically significant trend towards an improved PFS in heavy and light smokers compared to those who never smoked [34].